Shelley B. Thunen, Chief Financial Officer at RxSight, Inc. (RXST), sold 19,620 shares at $52.68 ($1.0M) on 2024-05-01, disclosed to the SEC on 2024-05-02.
Scheduled sale ($1.0M) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $52.68 | 9,620 | $507K | 49.0% |
| 2 | $52.68 | 9,620 | $507K | 49.0% |
| 3 | $53.04 | 380 | $20K | 1.9% |
| Total | $52.69 avg | 19,620 | $1.0M | 100% |
| Filing → |
| RXST | SELL | 2024-04-02 | $1.9M | — | Filing → |
| RXST | SELL | 2024-03-05 | $1.1M | — | Filing → |
| RXST | SELL | 2024-02-07 | $2.4M | — | Filing → |